OKYO Pharma (NASDAQ:OKYO) Trading 1.7% Higher – Here’s What Happened
by Kim Johansen · The Markets DailyOKYO Pharma Limited (NASDAQ:OKYO – Get Free Report)’s stock price rose 1.7% during trading on Monday . The stock traded as high as $1.22 and last traded at $1.18. Approximately 77,758 shares changed hands during mid-day trading, a decline of 32% from the average daily volume of 114,929 shares. The stock had previously closed at $1.16.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reiterated a “buy” rating and set a $7.00 price objective on shares of OKYO Pharma in a research report on Thursday, October 24th.
Read Our Latest Stock Report on OKYO
OKYO Pharma Trading Down 2.6 %
The firm’s fifty day moving average is $1.09 and its 200 day moving average is $1.12.
About OKYO Pharma
OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.
See Also
- Five stocks we like better than OKYO Pharma
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Work and Play: Investing in the Rise of Bleisure Travel
- Consumer Staples Stocks, Explained
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- 3 REITs to Buy and Hold for the Long Term
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business